{"id":6266,"date":"2021-07-13T11:44:47","date_gmt":"2021-07-13T11:44:47","guid":{"rendered":"https:\/\/hamslivenews.com\/?p=6266"},"modified":"2021-07-13T11:44:47","modified_gmt":"2021-07-13T11:44:47","slug":"dr-reddys-sputnik-covid-vaccine-has-reached-50-cities-towns-in-india","status":"publish","type":"post","link":"https:\/\/www.hamslive.com\/news\/2021\/07\/dr-reddys-sputnik-covid-vaccine-has-reached-50-cities-towns-in-india\/","title":{"rendered":"Dr. Reddy’s Sputnik COVID vaccine has reached 50 cities, towns in India"},"content":{"rendered":"

Dr. Reddy’s Labs announce that Russia’s Sputnik V vaccine which is being produced in India has reached 50 cities, towns in India.<\/h2>\n

The Russian Sputnik V vaccine was launched on a soft pilot basis in India on May 14 which is being produced in India and Dr Reddy’s Laboratories has stated that the nationwide soft launch of the Sputnik V vaccine has covered over 50 cities and towns, including Hyderabad, Bengaluru, Mumbai, Kolkata, Delhi NCR, and Chennai.<\/p>\n

Dr Reddy\u2019s plans to further strengthen the commercial roll-out of the Russian Covid-19 vaccine in the coming weeks.\u00a0\u00a0\u201cNeither the ongoing soft commercial launch nor work towards its ramp-up in India have been put on hold,\u201d said Dr Reddy\u2019s Labs in its latest statement.<\/p>\n

After commencing out in Hyderabad, the Sputnik V vaccine has also reached Vizag, Navi Mumbai, Miryalaguda, Vijayawada, Baddi, Kolhapur, Kochi, Raipur, Chandigarh, Pune, Nagpur, Nashik, Coimbatore, Ranchi, Jaipur, Lucknow, and Patna.<\/p>\n

The vaccine is also being administered in Bhubaneshwar, Guwahati, Thiruvananthapuram, Ahmedabad, Rajkot, Palakkad, Allahabad, Dimapur, Kohima, Indore, Bhopal, Surat, Cuttack, Dharwad, Ernakulam, Ratlam, Faridabad, Srinagar, Gandhinagar, Vadodara, Gulbarga, Madurai, Guntur, Kannur, Jabalpur, Jalandhar, Kanpur, and Mysore.<\/p>\n

Sputnik V vaccine is effective against many COVID variants including the new dangerous Delta variant claim their studies.\u00a0 The research paper by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology was published in a leading international medical journal on July 12 making this announcement.<\/p>\n

According to The Russian Direct Investment Fund (RDIF), the study was conducted to ascertain the Sputnik V vaccine’s neutralizing capacity against new variants of SARS-CoV-2.<\/p>\n

The study’s conclusions confirm that the Sputnik V vaccine has been able to produce protective neutralizing titers against new variants. These include the Alpha, Beta, Gamma, and very importantly, the Delta variant, which has been identified as one of the fundamental causes of the deadly second wave of COVID-19 infections.<\/p>\n

 <\/p>\n

 <\/p>\n

\n\t\t\t
\n\t\t\t <\/div><\/div>\n\t\t